![]() L-Carnitine has been recommended by medical professionals globally to individuals with genetic disorders whose bodies are unable to naturally synthesize carnitine. The report includes key understanding on the driving factors of this growth and also highlights the prominent players in the market and their developments. The global L Carnitine market was valued at US$ 172.2 Mn in 2018 and is projected to reach US$ 262.6 Mn by 2027 it is expected to grow at a CAGR of 4.8% during 2019 to 2027. It is used in the poultry industry to increase egg production and improve egg hatchability. It is also approved to be used in the treatment of carnitine deficiencies in patients at the end stage of renal diseases undergoing haemodialysis.īesides its uses in human nutrition, L-Carnitine is also used as an additive in the formulation of animal feed formulations. The US Food and Drug Administration (FDA) has approved the use of oral and intravenous (IV) L-Carnitine for treating primary and secondary carnitine deficiency.Īt present, L-Carnitine is commercially advertised as nutritional supplements to enhance exercise performance and promote weight loss. Individuals unable to synthesize L-Carnitine suffer from primary and secondary carnitine deficiency. HuangGang HuaYang Pharmaceutical Co., Ltd. ![]() ![]() The List of Companies - L-Carnitine Market
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |